FindTrial
Sign In

Role of Dalk in the management of Insomnia

A Study to evaluate the effectiveness of Dalk-e-Layyin Moâ??atadil with Roghan Labub-e-Saba in the control of Insomnia Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019731
Enrollment
53
Registered
2019-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F50-F59- Behavioral syndromes associated with physiological disturbances and physical factors

Interventions

Intervention1: Dalk e Layyin Moatadil: It is a type of massage which is done softly for the moderate duration. The massage will be done with Roghan labub e saba ( a unani formulation) on the forehead

Sponsors

School of Unani Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 to 60 years. 2. Males, Females and Trans-genders. 3. Patients complaining of insomnia who fulfill the diagnostic criteria of Insomnia Disorder of DSM â??V.

Exclusion criteria

Exclusion criteria: 1. Patients not fulfilling the diagnostic criteria of Insomnia Disorder of DSM- V. 2. Acute illness, fevers or painful conditions. 3. Known patients of Obstructive sleep apnea syndrome, Central Sleep -apnea Syndrome, Narcolepsy, Breathing related sleep disorder, Circadian rhythm sleep-wake disorder, Parasomnia. 4. Known cases of Restless Leg Syndrome, Periodic Limb Movement Disorder. 5. Alcohol or drug abuse with in past six months. 6. Pregnant and Lactating Women. 7. Patients with drug abuse and medication. 8. Known patients of Asthma. 9. Known Patients of Migraine or Headache. 10. Known Drug users of Glucocorticoids. 11. Known cases of Parkinson, Chorea, Epilepsy and Dementia. 12. Known patients of skin diseases like Eczema, Scabies and Psoriasis. 13. Known cases of Chronic Obstructive Pulmonary disease. 14. Known patients of Mental diseases. 15. Known patients of Cardiac disease. 16. Any other specific disease. 17. Participation in another study or previous participation in similar study.

Design outcomes

Primary

MeasureTime frame
Relieve in symptoms of Subjective parameters: 1. An inability to fall sleep 2. An inability to continue / maintain sleep 3. Restless wakening after night sleep 4. Sleepiness or tiredness during the day Assessment by Pittsburgh Sleep Quality Index and athens insomnia Scale for reliving of objective parametres Timepoint: assessment will be done on 15th day—

Secondary

MeasureTime frame
Assesment of mizaj of the patients of Insomnia disorderTimepoint: 1 Day—

Countries

India

Contacts

Public ContactSaba Fatma

Jamia Hamdard

drrubianjum@gmail.com7838447790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026